Moreover, PAR can accelerate the formation of pathogenic solid phase aggregates of an ALS-linked mutation of TDP-43 that is defective in LLPS ability (McGurk et al., 2018a). Here, TARDBP is linked to amyotrophic lateral sclerosis.